Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1983 1
1989 1
1994 1
1998 1
2001 2
2002 2
2003 1
2004 1
2006 1
2007 1
2008 5
2009 6
2010 4
2011 3
2012 3
2013 5
2014 4
2015 6
2016 2
2017 5
2018 5
2019 6
2020 7
2021 2
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
Moore KN, Angelergues A, Konecny GE, García Y, Banerjee S, Lorusso D, Lee JY, Moroney JW, Colombo N, Roszak A, Tromp J, Myers T, Lee JW, Beiner M, Cosgrove CM, Cibula D, Martin LP, Sabatier R, Buscema J, Estévez-García P, Coffman L, Nicum S, Duska LR, Pignata S, Gálvez F, Wang Y, Method M, Berkenblit A, Bello Roufai D, Van Gorp T; Gynecologic Oncology Group Partners and the European Network of Gynaecological Oncological Trial Groups. Moore KN, et al. N Engl J Med. 2023 Dec 7;389(23):2162-2174. doi: 10.1056/NEJMoa2309169. N Engl J Med. 2023. PMID: 38055253 Clinical Trial.
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Westin SN, Moore K, Chon HS, Lee JY, Thomes Pepin J, Sundborg M, Shai A, de la Garza J, Nishio S, Gold MA, Wang K, McIntyre K, Tillmanns TD, Blank SV, Liu JH, McCollum M, Contreras Mejia F, Nishikawa T, Pennington K, Novak Z, De Melo AC, Sehouli J, Klasa-Mazurkiewicz D, Papadimitriou C, Gil-Martin M, Brasiuniene B, Donnelly C, Del Rosario PM, Liu X, Van Nieuwenhuysen E; DUO-E Investigators. Westin SN, et al. J Clin Oncol. 2024 Jan 20;42(3):283-299. doi: 10.1200/JCO.23.02132. Epub 2023 Oct 21. J Clin Oncol. 2024. PMID: 37864337 Free PMC article. Clinical Trial.
Role of vitamin D3 in selected malignant neoplasms.
Markowska A, Antoszczak M, Kojs Z, Bednarek W, Markowska J, Huczyński A. Markowska A, et al. Among authors: bednarek w. Nutrition. 2020 Nov-Dec;79-80:110964. doi: 10.1016/j.nut.2020.110964. Epub 2020 Jul 30. Nutrition. 2020. PMID: 32877827 Review.
[Endometriosis in adolescents].
Polak G, Bednarek W, Wertel I, Kwaśniewski W, Wasyluk T, Raganowski P, Kotarski J. Polak G, et al. Among authors: bednarek w. Wiad Lek. 2013;66(2 Pt 2):192-4. Wiad Lek. 2013. PMID: 25775816 Review. Polish.
Management of uterine leiomyosarcoma.
Bobiński M, Kraczkowski JJ, Witt E, Wertel I, Polak G, Kotarski J, Bednarek W. Bobiński M, et al. Among authors: bednarek w. Wiad Lek. 2016;69(6):799-803. Wiad Lek. 2016. PMID: 28214818 Review.
Microvessels Density in Uterine Leiomyosarcoma.
Bobiński M, Bednarek W, Szumiło J, Cybulski M, Polak G, Kotarski J. Bobiński M, et al. Among authors: bednarek w. Biomed Res Int. 2015;2015:475305. doi: 10.1155/2015/475305. Epub 2015 Jun 16. Biomed Res Int. 2015. PMID: 26161403 Free PMC article.
Immunohistochemical Expression of Vitamin D Receptor in Uterine Fibroids.
Markowska A, Kurzawa P, Bednarek W, Gryboś A, Mardas M, Krzyżaniak M, Majewski J, Markowska J, Gryboś M, Żurawski J. Markowska A, et al. Among authors: bednarek w. Nutrients. 2022 Aug 17;14(16):3371. doi: 10.3390/nu14163371. Nutrients. 2022. PMID: 36014877 Free PMC article.
80 results